SCHEMBL3504880

SCHEMBL3504880

COc1ccc2onc(NCCN3CCOCC3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.56
▸ CYP1A2 P05177 4/20 0.56
▸ CYP3A4 P08684 4/20 0.56
▸ CYP2D6 P10635 4/20 0.56
▸ USP2 O75604 3/20 0.56
▸ CLK4 Q9HAZ1 3/20 0.56
▸ KDM4E B2RXH2 5/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ HSD17B10 Q99714 5/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ LMNA P02545 4/20 0.52
▸ TP53 P04637 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ KMT2A Q03164 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6959886 0.91 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL3503323 0.84 HSP90AA1 (0.45) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL6953674 0.82 HSP90AA1 (0.55) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL3506032 0.82 CYP1A2 (0.50) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL3505036 0.79 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL3510105 0.78 ALDH1A1 (0.50) ALDH1A1USP2KDM4ERAB9AHSD17B10
SCHEMBL8183130 0.77 CYP3A4 (0.47) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL6957700 0.76 DRD3 (0.45) ALDH1A1KDM4EHPGDNPSR1TSHR
SCHEMBL8184622 0.76 CYP3A4 (0.45) ALDH1A1CYP1A2CYP3A4CYP2D6USP2
SCHEMBL3504318 0.76 ACHE (0.41) ALDH1A1CYP1A2CYP3A4CYP2D6USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US claimed
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 — — US disclosed
EP-2195029-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES Oryzon Genomics SA (ES) 2010-06-16 — — EP disclosed
WO-2009027349-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS SA (ES) 2009-03-05 — — WO disclosed
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-6046203-A USEFUL FOR THE TREATMENT OF VARIOUS MEMORY DYSFUNCTIONS CHARACTERIZED BY A DECREASED CHOLINERGIC FUNCTION SUCH AS ALZHEIMER'S DISEASE; ALSO INHIBIT MONOAMINE OXIDASE AND HENCE ARE USEFUL AS ANTIDEPRESSANTS AVENTIS PHARMACEUTICALS INC. (US) 2000-04-04 — — US disclosed
US-5925766-A COGNITION ACTIVATORS FOR DECREASING CHOLINERGIC FUNCTION OF ALZHEIMER*S DISEASE AND ARE ENZYME INHIBITORS OF MONOAMINE OXIDASE AND ARE ANTIDEPRESSANTS HOECHST MARION ROUSSEL, INC. (US) 1999-07-20 — — US disclosed
US-5756754-A Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds HOECHST MARION ROUSSEL, INC. (US) 1998-05-26 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
EP-0669920-A4 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS. HOECHST ROUSSEL PHARMA (US) 1995-10-25 — — EP disclosed
EP-0669920-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST MARION ROUSSEL, Inc. (US) 1995-09-06 — — EP disclosed
WO-1994012495-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-06-09 — — WO disclosed
Send feedback